PLSE · Pulse Biosciences, Inc.
$35.17
-0.30 (-0.85%)
At close · Jul 29
Market Cap
$2.45B
Shares
69.21M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-01 | $60,000,000 | $59,976,196 | 2026-02-18 | — | 8-K , filed 2026-02-19 |
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
13 filings
13 filers
Visit website
Investor relations